Stem cell-based in vitro models as alternative methods for toxicity and efficacy tests in animals;Stammzellbasierte In-vitro-Modelle als Ersatz für Tiermodelle bei Toxizitäts- und Wirksamkeitsprüfungen

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 51, Issue 9, 2008, Pages 1033-1038

  Klemm, M ^a   Groebe, K ^a   Soskic V ^a   Schrattenholz, André ^a  

^a PROTEOSYS AG   (Germany)

Author keywords

Embryo toxicity; Molecular end points; Neural differentiation; Stem cells

Indexed keywords

NEW DRUG;

ANIMAL; ANIMAL TESTING ALTERNATIVE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CYTOLOGY; DEGENERATIVE DISEASE; DRUG EFFECT; EMBRYO RESEARCH; EMBRYONIC STEM CELL; GENETICS; HUMAN; LEGAL ASPECT; MOUSE; NERVE CELL; PATHOLOGY; PROTEOMICS;

ANIMAL TESTING ALTERNATIVES; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; DRUGS, INVESTIGATIONAL; EMBRYO RESEARCH; EMBRYONIC STEM CELLS; HUMANS; MICE; NEURODEGENERATIVE DISEASES; NEURONS; PROTEOMICS;

EID: 52349089376     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-008-0632-4     Document Type: Article

References (26)

1. Schrattenholz A, Klemm M (2007) How human embryonic stem cell research can impact in vitro drug screening technologies of the future. In: Marx U, Sandig V (eds) Drug testing in vitro: break-throughs and trends in cell culture technology. Wiley/VCH Weinheim, S 205-228
2. Genschow 2002 Altern Lab Anim 30 151
3. Genschow 2004 Altern Lab Anim 32 209
4. Seiler 2004 Reprod Toxicol 18 231
5. Piersma 2004 Altern Lab Anim 32 275
6. Seiler 2006 ALTEX 23 393
7. Schrattenholz 2007 ALTEX 24 9
8. Schrattenholz 2006 Curr Top Med Chem 6 663
9. Metzger 2005 J Neurosci Methods 141 309
10. Schillo 2005 J Proteome Res 4 900
11. Sommer 2004 J Proteome Res 3 572
12. Soskic V, Klemm M, Proikas-Cezanne T, et al. (2008) A connection between the mitochondrial permeability transition pore, autophagy and cerebral amyloidogenesis. J Proteome Res (in press)
13. Hareng 2005 Reprod Toxicol 20 441
14. Groebe 2007 Exp Gerontol 42 887
15. Hunzinger 2006 J Chromatogr A 1123 170
16. Hunzinger 2006 J Proteome Res 5 625
17. Neubauer 2006 Electrophoresis 27 1840
18. Poznanovic 2005 J Proteome Res 4 2117
19. Schrattenholz 2007 Electrophoresis 28 1970
20. Soskic 2008 Exp Gerontol 43 247
21. Köllermann J, Schlomm T, Bang H, et al. (2008) Expression and prognostic relevance of Annexin A3 in prostate cancer. Eur Urol 16: (Epub ahead of print)
22. Schostak M, Schwall GP, Poznanović P, et al. (2008) Annexin A3 in urine - a highly specific non invasive marker in prostate cancer early detection. J Urology (in press)
23. Amaro 1996 Chem Res Toxicol 9 623
24. Schrattenholz A, Soskic V (2008) What does systems biology mean for drug development? Curr Top Med Chem (in press)
25. Groebe 2007 Exp.Gerontol 42 887
26. Balls 1995 Altern Lab Anim 23 838